File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Scopus: eid_2-s2.0-0033660521
- PMID: 11117243
- WOS: WOS:000165418400007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells
Title | Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells |
---|---|
Authors | |
Keywords | Cytokine Matrix metalloproteinase Mesothelial cells Tissue inhibitors of metalloproteinases |
Issue Date | 2000 |
Publisher | Multimed, Inc. The Journal's web site is located at http://pdiconnect.com |
Citation | Peritoneal Dialysis International, 2000, v. 20 n. 5, p. 524-533 How to Cite? |
Abstract | Objective: Human peritoneal mesothelial cells (HPMC) are likely to be involved in maintenance of the peritoneal membrane. We determined whether these cells were able to synthesize the matrix degrading enzymes, matrix metalloproteinases (MMPs), likely to be responsible for the breakdown of this membrane, and whether this secretion could be modulated by cytokines involved in the inflammatory response. Design: MMP activity in conditioned medium of growth-arrested HPMC was measured by zymography. Cultures were incubated in the presence and absence of the cytokines transforming growth factor-beta (TGFβ) and interleukin (IL)-1β in order to determine the effects of these cytokines on this process. The mRNA for these MMPs, together with that of their specific inhibitors, tissue inhibitors of metalloproteinases (TIMPs), was also examined by reverse transcriptase polymerase chain reaction (RT-PCR). Results: HPMC were shown to constitutively secrete the metalloproteinases MMP-2 and MMP-3 in vitro. In response to the proinflammatory cytokine IL-1β, the protein and mRNA for MMP-9 was induced, while secretion of MMP-2 was unaltered. Similarly, the mRNA for MMP-3 was also increased relative to actin following the addition of IL-1β. TGFβ was shown to slightly induce the secretion of MMP-2 together with the mRNA for TIMP I, TIMP II, and, to a greater extent, TIMP III. Used peritoneal dialysate was also shown to induce MMP-9 secretion, and this effect was blocked by the co-incubation of IL-1 receptor antagonist. The secretion of enzyme activity was shown to be from the apical surface of the cells. Conclusion: HPMC have the ability to control the accumulation of extracellular matrix by secreting the matrix degrading molecules MMP-2, MMP-3, and MMP-9. In addition, the secretion of these enzymes, together with that of their inhibitors (TIMPs) is regulated by the cytokines IL-1β and TGFβ. This process is likely to be important in both the normal maintenance of the integrity of the peritoneal membrane and in the changes that occur following prolonged peritoneal dialysis. |
Persistent Identifier | http://hdl.handle.net/10722/162369 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 0.933 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Martin, J | en_US |
dc.contributor.author | Yung, S | en_US |
dc.contributor.author | Robson, RL | en_US |
dc.contributor.author | Steadman, R | en_US |
dc.contributor.author | Davies, M | en_US |
dc.date.accessioned | 2012-09-05T05:19:19Z | - |
dc.date.available | 2012-09-05T05:19:19Z | - |
dc.date.issued | 2000 | en_US |
dc.identifier.citation | Peritoneal Dialysis International, 2000, v. 20 n. 5, p. 524-533 | en_US |
dc.identifier.issn | 0896-8608 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/162369 | - |
dc.description.abstract | Objective: Human peritoneal mesothelial cells (HPMC) are likely to be involved in maintenance of the peritoneal membrane. We determined whether these cells were able to synthesize the matrix degrading enzymes, matrix metalloproteinases (MMPs), likely to be responsible for the breakdown of this membrane, and whether this secretion could be modulated by cytokines involved in the inflammatory response. Design: MMP activity in conditioned medium of growth-arrested HPMC was measured by zymography. Cultures were incubated in the presence and absence of the cytokines transforming growth factor-beta (TGFβ) and interleukin (IL)-1β in order to determine the effects of these cytokines on this process. The mRNA for these MMPs, together with that of their specific inhibitors, tissue inhibitors of metalloproteinases (TIMPs), was also examined by reverse transcriptase polymerase chain reaction (RT-PCR). Results: HPMC were shown to constitutively secrete the metalloproteinases MMP-2 and MMP-3 in vitro. In response to the proinflammatory cytokine IL-1β, the protein and mRNA for MMP-9 was induced, while secretion of MMP-2 was unaltered. Similarly, the mRNA for MMP-3 was also increased relative to actin following the addition of IL-1β. TGFβ was shown to slightly induce the secretion of MMP-2 together with the mRNA for TIMP I, TIMP II, and, to a greater extent, TIMP III. Used peritoneal dialysate was also shown to induce MMP-9 secretion, and this effect was blocked by the co-incubation of IL-1 receptor antagonist. The secretion of enzyme activity was shown to be from the apical surface of the cells. Conclusion: HPMC have the ability to control the accumulation of extracellular matrix by secreting the matrix degrading molecules MMP-2, MMP-3, and MMP-9. In addition, the secretion of these enzymes, together with that of their inhibitors (TIMPs) is regulated by the cytokines IL-1β and TGFβ. This process is likely to be important in both the normal maintenance of the integrity of the peritoneal membrane and in the changes that occur following prolonged peritoneal dialysis. | en_US |
dc.language | eng | en_US |
dc.publisher | Multimed, Inc. The Journal's web site is located at http://pdiconnect.com | en_US |
dc.relation.ispartof | Peritoneal Dialysis International | en_US |
dc.subject | Cytokine | - |
dc.subject | Matrix metalloproteinase | - |
dc.subject | Mesothelial cells | - |
dc.subject | Tissue inhibitors of metalloproteinases | - |
dc.subject.mesh | Base Sequence | en_US |
dc.subject.mesh | Cells, Cultured | en_US |
dc.subject.mesh | Epithelium - Enzymology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interleukin-1 - Pharmacology | en_US |
dc.subject.mesh | Matrix Metalloproteinase 2 - Metabolism | en_US |
dc.subject.mesh | Matrix Metalloproteinase 3 - Metabolism | en_US |
dc.subject.mesh | Matrix Metalloproteinases - Drug Effects - Metabolism | en_US |
dc.subject.mesh | Molecular Sequence Data | en_US |
dc.subject.mesh | Peritoneum - Cytology - Enzymology | en_US |
dc.subject.mesh | Reverse Transcriptase Polymerase Chain Reaction | en_US |
dc.subject.mesh | Sensitivity And Specificity | en_US |
dc.subject.mesh | Transforming Growth Factor Beta - Pharmacology | en_US |
dc.title | Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells | en_US |
dc.type | Article | en_US |
dc.identifier.email | Yung, S:ssyyung@hku.hk | en_US |
dc.identifier.authority | Yung, S=rp00455 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.pmid | 11117243 | - |
dc.identifier.scopus | eid_2-s2.0-0033660521 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0033660521&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 20 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.spage | 524 | en_US |
dc.identifier.epage | 533 | en_US |
dc.identifier.isi | WOS:000165418400007 | - |
dc.publisher.place | Canada | en_US |
dc.identifier.scopusauthorid | Martin, J=7501553184 | en_US |
dc.identifier.scopusauthorid | Yung, S=22636568800 | en_US |
dc.identifier.scopusauthorid | Robson, RL=7102721727 | en_US |
dc.identifier.scopusauthorid | Steadman, R=7005620093 | en_US |
dc.identifier.scopusauthorid | Davies, M=7404207291 | en_US |
dc.identifier.issnl | 0896-8608 | - |